LivaNova reports Q3 2026 and raises full-year revenue and adjusted EPS guidance
FROM THE WIRE · BUSINESSWIRE.COM
GLOUCESTER, England--(BUSINESS WIRE)---- $LIVN #OSA--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the third quarter ended September 30, 2026 and raised full-year 2026 guidance. Financial Summary and Highlights(1)…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishA raised revenue and adjusted EPS guidance is a positive signal for the stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Third-quarter revenue was $393.1 million, up 9.9% reported.
- 02U.S. GAAP diluted EPS was $0.11.
- 03The company raised 2026 guidance for revenue and adjusted diluted EPS.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets